A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A
in the treatment of glabellar lines.
Botulinum toxin type A
can be used to verify whether the pain is muscular or pulpal (e.
Subcutaneous botulinum toxin type A
reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin.
Clinicians should consider all associated clinical conditions in patients with IS and, botulinum toxin type A
may be used for symptomatic relief in clinically appropriate cases.
A randomized, double masked, controlled trial of botulinum toxin type A
in essential hand tremor.
At first, the patient was thought to have Miller-Fisher variant of Guillain-Barre syndrome, but subsequent testing of his serum showed a positive result for botulinum toxin type A
The five patients in the experimental treatment group received 50 U of botulinum toxin type A
at the plantar fascia insertion, 50 U at the motor point of the soleus muscle, and 25 U at both the medial and lateral gastrocnemius motor points.
Botulinum toxin type A
was detected in the serum of one Indiana patient and in a leftover chili mixture obtained from his home.
He said he uses 5-150 units of botulinum toxin type A
(Botox) or 250-1,000 units of botulinum toxin type B (Myobloc) for drooling.
Originally discovered in the late 1980s to treat neurological disorders, botulinum toxin type A
is the same medication that is used in much smaller doses to treat wrinkles.
The agreement gives Q-Med the exclusive rights to distribute Medy-Tox's botulinum toxin type A
product in Europe, excluding Russia.
Botulinum toxin Type A
for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
Abstract: This review assessed the overall effectiveness of repeated treatments with botulinum toxin type A
(BoNTA) across different conditions, as documented in the published literature.
On July 20, the Food and Drug Administration approved injections of botulinum toxin type A
, which Allergan markets as Botox, for treating hyperhidrosis that doesn't improve with other nonsurgical treatments, such as antiperspirant ointments.
This is the first large trial to show that botulinum toxin type A
improved function and muscle tone following a stroke," said Indiana University neurologist Allison Brashear, principal investigator of the study.